Increasing costs in psychotic disorders to strain US healthcare system Comment 10 February 2013 Pages: 2 - 2
UK watchdog agency tackles cost efficacy on national scale Meeting report 10 February 2013 Pages: 3 - 4
Antidepressant therapy duration inadequate in US paediatrics Clinical study 10 February 2013 Pages: 6 - 6
Education programme reduces costs in ventilator-associated pneumonia Clinical study 10 February 2013 Pages: 6 - 6
Prescribing in type 2 diabetes mellitus changing in Sweden Clinical study 10 February 2013 Pages: 6 - 6
Early sumatriptan use improves outcomes, cuts costs in migraine Clinical study 10 February 2013 Pages: 7 - 7
Psychological factors predict patient satisfaction with PCA Clinical study 10 February 2013 Pages: 7 - 7
Hospital costs of diabetes vary with method used to attribute costs Clinical study 10 February 2013 Pages: 9 - 9
Paracetamol vs NSAID prescribing among the elderly in Canada Clinical study 10 February 2013 Pages: 9 - 9
Psychiatric resource use higher for cancer vs no cancer history Clinical study 10 February 2013 Pages: 9 - 9
Oxygen therapy clinic beneficial in respiratory tract disorders Clinical study 10 February 2013 Pages: 10 - 10
QOL improves for antibacterial programme enrollees in Canada Clinical study 10 February 2013 Pages: 10 - 10
Reduced US health plan drug spending due to Rx drug rebates News item 10 February 2013 Pages: 11 - 11
Positive etanercept results to be seen in psoriasis market? News item 10 February 2013 Pages: 12 - 12
Three-fold rise in pharmacogenomics market forecast to 2008 News item 10 February 2013 Pages: 12 - 12